Full Prescribing Info
Dosage/Direction for Use

Peripheral vascular disease
Adult: Initially, 40 mg 4 times daily, increase to 80 mg 4 times daily if necessary. Withdraw if no response in 2 wk.
Active liver disease, pregnancy, lactation.
Special Precautions
DM (insulin requirements may be reduced); monitor liver function.
Adverse Reactions
Nausea; diarrhoea; flushing; headache; dizziness; dry mouth; nasal congestion; hepatotoxicity.
Hypotension is the main symptom. Nurse patient in the supine position until BP returns to normal.
Drug Interactions
May enhance effects of antihypertensives. Hypotensive effect may be enhanced by TCAs.
Moxisylyte is an α-adrenoceptor blocker with vasodilating activity.
Oral: Store below 30°C.
ATC Classification
C04AX10 - moxisylyte ; Belongs to the class of other peripheral vasodilators.
G04BE06 - moxisylyte ; Belongs to the class of drugs used in erectile dysfunction.
Disclaimer: This information is independently developed by CIMS based on moxisylyte from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in